- The Effect of Subconjunctival Injection of Liposome Encapsulated Cytarabine on Proliferation of Fibroblasts
-
Seong GJ, Hong YJ, Park SJ
- KMID: 1949975
- J Korean Ophthalmol Soc.
- 1992 Sep;33(9):885-891.
To know the effect of subconjunctival injection of liposome encapsulated cytarabine on proliferation of conjunctival fibroblasts, the conjunctiva was isolated at 180 degrees from the injection site 3 days after... -
- CITED
-
- Close
- SHARE
-
- Close
- Intrapleural chemotherapy with cisplatin and cytarabine in the management of malignant pleural effusion
-
Chang J
- KMID: 2306246
- Korean J Med.
- 2000 Feb;58(2):250-252.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Salvage chemotherapy with R-BAD (rituximab, bendamustine, cytarabine, and dexamethasone) for the treatment of relapsed primary CNS lymphoma
-
Cho MS, Kim JY, Jung SY, Ahn SY, Song GY, Yang DH
- KMID: 2364322
- Blood Res.
- 2016 Dec;51(4):285-287.
- doi: 10.5045/br.2016.51.4.285
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Successful desensitization for cytarabine induced anaphylaxis
-
Lee HW, Park JY, Moon JH, Park KT, Park HK, Kang HR
- KMID: 1803550
- Allergy Asthma Respir Dis.
- 2014 Nov;2(5):394-397.
- doi: 10.4168/aard.2014.2.5.394
Cytarabine is a very important chemotherapeutic agent for leukemia and lymphoma patients and is prescribed more frequently than before. Cytarabine-induced delayed-onset hypersensitivity may rarely present as non-IgE mediated anaphylaxis. However,... -
- CITED
-
- Close
- SHARE
-
- Close
- High-Dose Cytosine Arabinoside (HD Ara-C) Therapy for Refractory Acute Leukemia in Children
-
Ha IS, Ahn HS, Hong CY
- KMID: 1682674
- J Korean Pediatr Soc.
- 1988 Oct;31(10):1328-1337.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Phase I clinical trial of simultaneous administration of intraperitoneal carboplatin, etoposide and cytosine arabinoside for refractory ovarian carcinoma
-
Suh HS
- KMID: 2259404
- Korean J Obstet Gynecol.
- 1992 Apr;35(4):571-588.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Combination chemotherapy with TAD(6-thioguanine, Ara-C and daunorubicin) in acute myelogenous leukemia
-
Ahn HS, Lee YC, Park CH, Yim CY
- KMID: 1688080
- Korean J Hematol.
- 1991 Jun;26(1):73-80.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Complete Remission in a 71-year-old Patient with AML-M7 after Low-dose Cytarabine Induction and Intermediate-dose Cytarabine Consolidation Treatment
-
Kwon JH, Kim JW, Park JH, Koh Y, Kim JH, Bang SM, Song J, Lee JS
- KMID: 2252103
- Korean J Hematol.
- 2009 Dec;44(4):244-248.
- doi: 10.5045/kjh.2009.44.4.244
The authors describe the case of a 71-year-old patient with acute megakaryocytic leukemia (AML-M7) who was successfully treated with low-dose cytarabine induction followed by intermediate-dose cytarabine consolidation therapy. The patient... -
- CITED
-
- Close
- SHARE
-
- Close
- Rehabilitation for Ataxia Following Chemotherapy for Burkitt Lymphoma Involving the Rectum
-
Kim HS, Jung CO, Jeon HR, Sung LH
- KMID: 2266733
- Ann Rehabil Med.
- 2012 Aug;36(4):578-583.
- doi: 10.5535/arm.2012.36.4.578
Burkitt lymphoma is a type of B-cell lymphoma that occurs mostly in children, and rarely in adults. The sporadic type is known to occur mostly at the ileum and cecum.... -
- CITED
-
- Close
- SHARE
-
- Close
- Intrathecal Chemotherapy Related Myelopathy Improved With Folate and Cyanocobalamin
-
Park SY, Park HR, Kim JE, Sung JJ
- KMID: 2343409
- J Korean Neurol Assoc.
- 2011 Aug;29(3):224-226.
Intrathecal chemotherapy with methotrexate and cytarabine arabinoside is used for the treatment and prophylaxis of malignancies, but can induce myelopathy. We report the case of a 50-year-old woman with stomach... -
- CITED
-
- Close
- SHARE
-
- Close
- Standard Induction Followed by Low Dose Cytarabine for the Treatment of Acute Myeloid Leukemia of Down Syndrome
-
Kyung YC, Choi YB, Lee NH, Lee SH, Sung KW, Koo HH, Yoo KH
- KMID: 2279816
- Clin Pediatr Hematol Oncol.
- 2014 Oct;21(2):80-85.
- doi: 10.0000/cpho.2014.21.2.80
BACKGROUND: Although acute myeloid leukemia occurring in patients with Down syndrome (AML-DS) is generally chemosensitive, these patients are more susceptible to regimen-related toxicities, and the optimal post-remission therapy for AML-DS... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of the Cauda Equina Syndrome Associated With the Intrathecal Chemotherapy in a Patient With Primary Central Nervous System Lymphoma
-
Park S, Kang JI, Bang H, Kim BR, Lee J
- KMID: 2219540
- Ann Rehabil Med.
- 2013 Jun;37(3):420-425.
- doi: 10.5535/arm.2013.37.3.420
The intrathecal chemotherapy with methotrexate and cytarabine arabinoside is used for the treatment and prophylaxis of the primary central nervous system lymphoma. The therapy may induce neurotoxicity including the cauda... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic Implications of Cytarabine Dose in Consolidation Chemotherapy for the Patients with Acute Myelogenous Leukemia
-
Lee JH, Lee JH, Lee KH, Bahng H, Ahn JH, Lee JS, Kim SH, Kim WK
- KMID: 1815313
- J Korean Cancer Assoc.
- 2000 Oct;32(5):954-961.
PURPOSE: Increasing the dose of cytarabine in consolidation chemotherapy has been suggested to improve treatment outcome of the patients with acute myelogenous leukemia (AML) in complete remission (CR). We studied... -
- CITED
-
- Close
- SHARE
-
- Close
- Mitoxantrone and cytosine arabinoside in adult patients with refractory and relapsed acute leukemia
-
Lee JY, Shin HC, Park YS, Jang JS, Im YH, Yoon SS, Park SY, Kim BK, Kim NK
- KMID: 1688363
- Korean J Hematol.
- 1993 Nov;28(2):257-265.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Combination chemotherapy with cytosine arabinoside and idarubicin for acute myelogenous leukemia
-
Shin HC, Jung CW, Lee JH, Lee JA, Yang SH, Leem YH, Park SY, Kim BK, Kim NK
- KMID: 1688361
- Korean J Hematol.
- 1993 Nov;28(2):247-255.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of Acute Myelogenous Leukemia in Children: Remission Induction with Adriamycin and Cytosine Arabinoside, and Postremission Maintenance Chemotherapy with Adriamycin, Cytosine Arabinoside and 6-thioguanine
-
Kim SK, Ahn HS, Hong CY
- KMID: 1682617
- J Korean Pediatr Soc.
- 1988 Jul;31(7):850-862.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Cytarabine Plus Daunorubicin or Idarubicin as Induction Chemotherapy for the Patients with De novo Acute Myelogenous Leukemia
-
Ahn JH, Lee JH, Lee KH, Bahng H, Lee JH, Lee JS, Kim SH, Kim WK
- KMID: 2143343
- Korean J Hematol.
- 2000 Nov;35(3-4):214-221.
BACKGROUND: The combination of cytarabine plus anthracycline has been considered standard chemotherapy for acute myelogenous leukemia (AML). We retrospectively analyzed the treatment results of the patients with de novo AML... -
- CITED
-
- Close
- SHARE
-
- Close
- Renission induction chemotherapy with idarubicin and cytosine arabinoside for the patients with acute myelogenous leukemia
-
Jin JY, Uhm HS, Jeon DS, Lee JW, Han CH, Min WS, Park CW, Kim CC, Kim DJ, Choi WK, Kim HK
- KMID: 2252478
- Korean J Hematol.
- 1991 Oct;26(2):281-287.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Transitional Cell Tumor Culture and Chemosensitivity Test: Preliminary Report
-
Choi NG, Lee KM
- KMID: 1912778
- Korean J Urol.
- 1989 Feb;30(1):1-6.
Usually, tumor stem cells have been assessed functionally in animals with various in vivo transplantation assays or with in vitro colony forming assays. Such studies indicate the tumor stem cell... -
- CITED
-
- Close
- SHARE
-
- Close
- Cytarabine and Idarubicin Induction Chemotherapy in Patients with Acute Myelogenous Leukemia
-
Lee JS, Bang SM, Ju KT, Ahn JY, Cho YK, Cho EK, Shin DB, Lee JH
- KMID: 1832117
- Korean J Hematol.
- 2001 May;36(2):129-135.
BACKGROUND: About 60~80% of previously untreated patients with acute myelogenous leukemia (AML) achieve complete remission (CR) when treated with cytarabine and anthracycline. Anthracycline is one of the most important chemotherapeutic... -
- CITED
-
- Close
- SHARE
-
- Close
